BB
BridgeBio Pharma Inc.
BBIO · BridgeBio Pharma Inc. · Healthcare
Up next day
6/12
50%
Fell despite growth
3/12
Good earnings ignored
Avg earnings move
±2.7%
typical swing on earnings
Price when beating
+0.3%
avg over 3 beats
Biggest single move
-8.9%
'25.6 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Tends to run up in the week before earnings
Rose beforehand 9 of last 12 · avg +4.9% · expectations build early
Good results usually push the stock up
Up the next day 2 of 3 beats (67%)
Reaction is erratic and hard to predict
Avg +0.3% on a beat, -0.4% on a miss
vs Healthcare sector avg (153 peers)
This
-0.2%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
The number and guidance move the price about equally
Moved opposite to results 5 of last 12 times (42%)
1xBeat but fell
Even a beat sells off if guidance disappoints
4xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Oct 28After close
'26.9 expectedEst. EPS $-0.67
Quarter ended 6/2026
Reported 2026-08-10
Next-day move
-1.1%
After 5 days -5.7%
vs Consensus$-0.58→$-0.78-33.9% miss
EPS
$-0.78
YoY +18%
Revenue
$0.2B
YoY +120%
Next-Q guidance
—
N/A
Price around earnings
+26% run-up before
Earnings trend · last 12 quarters
EPS$-0.78YoY +18%
'23.9'26.6
Revenue$0.2BYoY +120%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
5x42%
Met expectations
good · up ↑
1x8%
Disappointment
weak · down ↓
1x8%
Good earnings ignored
good · down ↓
5x42%
← ← Weak earningsStrong earnings → →
Price rose even on weak earnings — bad news priced in / buy-the-dip · 5 of 12q (42%)
Community · BBIO
What do you think of this stock's earnings pattern?
···